119 related articles for article (PubMed ID: 9398146)
1. Androgens, erythropoietin, iron stores, and lipoprotein (a) in hemodialysis patients.
Fourtounas C; Tzanatos H; Fourtounas C; Kopelias I; Agroyannis B
Am J Kidney Dis; 1997 Dec; 30(6):935-6. PubMed ID: 9398146
[No Abstract] [Full Text] [Related]
2. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
[TBL] [Abstract][Full Text] [Related]
3. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.
Gaughan WJ; Liss KA; Dunn SR; Mangold AM; Buhsmer JP; Michael B; Burke JF
Am J Kidney Dis; 1997 Oct; 30(4):495-500. PubMed ID: 9328363
[TBL] [Abstract][Full Text] [Related]
4. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
Barton Pai A; Chretien C; Lau AH
Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
[TBL] [Abstract][Full Text] [Related]
5. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
Ballal SH; Domoto DT; Polack DC; Marciulonis P; Martin KJ
Am J Kidney Dis; 1991 Jan; 17(1):29-33. PubMed ID: 1986567
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
Berns JS; Rudnick MR; Cohen RM
Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
[TBL] [Abstract][Full Text] [Related]
7. Effect of androgen administration on the action of exogenous erythropoietin in hemodialysis patients.
Sombolos K; Zoumbaridis N; Mavromatidis K; Natse T
Am J Kidney Dis; 1992 Jan; 19(1):94. PubMed ID: 1739091
[No Abstract] [Full Text] [Related]
8. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
Sheashaa H; Abdel-Razek W; El-Husseini A; Selim A; Hassan N; Abbas T; El-Askalani H; Sobh M
Nephron Clin Pract; 2005; 99(4):c102-6. PubMed ID: 15703460
[TBL] [Abstract][Full Text] [Related]
9. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.
Gascón A; Belvis JJ; Berisa F; Iglesias E; Estopiñán V; Teruel JL
Geriatr Nephrol Urol; 1999; 9(2):67-72. PubMed ID: 10518249
[TBL] [Abstract][Full Text] [Related]
10. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
Navarro JF; Mora C; Macía M; García J
Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
[TBL] [Abstract][Full Text] [Related]
11. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
Johansen KL
Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
[No Abstract] [Full Text] [Related]
12. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
Mora C; Macía ML; García J; Navarro JF
Perit Dial Int; 2001; 21(6):611-4. PubMed ID: 11783772
[No Abstract] [Full Text] [Related]
13. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study.
Teruel JL; Marcén R; Navarro JF; Villafruela JJ; Fernández Lucas M; Liaño F; Ortuño J
Nephron; 1995; 70(3):282-6. PubMed ID: 7477614
[TBL] [Abstract][Full Text] [Related]
14. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Johansen KL; Mulligan K; Schambelan M
JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
[TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
Need AG; Nordin BE; Chatterton BE
Osteoporos Int; 1993; 3 Suppl 1():218-22. PubMed ID: 8461566
[No Abstract] [Full Text] [Related]
16. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
Chhaparwal M; Saraf ML
Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
[No Abstract] [Full Text] [Related]
17. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
[TBL] [Abstract][Full Text] [Related]
18. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
[No Abstract] [Full Text] [Related]
19. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
20. [Prophylaxis and treatment of osteoporosis].
Kopera H
Klin Wochenschr; 1989 May; 67(10):557-8. PubMed ID: 2739351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
